Treatment of Enterococcus faecalis Chronic Prostatitis

First-Line Treatment Regimen

• The Infectious Diseases Society of America recommends linezolid 600 mg orally every 12 hours as the backbone of therapy due to its proven efficacy against enterococcal infections, including resistant strains 1
• For pulse therapy, administer linezolid for 2 weeks, followed by a 1-week rest period to minimize the risk of myelosuppression and peripheral neuropathy 1

Special Considerations

• For patients with vancomycin-resistant E. faecalis, linezolid remains the cornerstone of therapy 1
• For patients unable to tolerate linezolid, consider high-dose daptomycin (8-12 mg/kg/day) as an alternative, though it may have less prostatic penetration 1

Treatment Success Evaluation

• Consider additional cycles if symptoms persist but are improving with each cycle 1
• Complete 2-3 cycles of the pulse therapy (each cycle: linezolid 2 weeks → 1-week rest → levofloxacin 2 weeks) 1

Interval Pulse Therapy for Enterococcus faecalis Chronic Prostatitis

Treatment Rationale and Evidence

• Chronic bacterial prostatitis (CBP) caused by Enterococcus faecalis is challenging to treat due to limited antibiotic penetration into prostatic tissue and increasing antimicrobial resistance, as noted by the JAMA network open 2

Special Considerations

• For vancomycin-resistant E. faecalis strains, linezolid remains particularly effective, according to Circulation 3
• Consider adding gentamicin during the first treatment cycle if rapid bacterial reduction is needed, as it shows synergistic effects with both agents, as reported in the Journal of Microbiology, Immunology and Infection 4

Potential Pitfalls and Caveats

• Guidelines note there is insufficient evidence for clear recommendations on duration of treatment for chronic bacterial prostatitis, suggesting individualization based on clinical response, as stated in the JAMA network open 2